Johnson & Johnson insider plans 21,721-share sale on NYSE
Rhea-AI Filing Summary
Johnson & Johnson (JNJ) filed a Form 144 notice covering a proposed sale of 21,721 shares of common stock with an aggregate market value of $4,185,794.26. The filing lists an approximate sale date of 10/17/2025 on the NYSE through Fidelity Brokerage Services LLC.
The securities were acquired on 10/17/2025 via an option granted on 02/15/2024, with payment made on 10/17/2025 in cash. The notice states 2,408,338,872 shares outstanding. Over the past three months, John C. Reed sold 19,137 shares on 07/17/2025 for gross proceeds of $3,129,830.51.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 for insider sales; limited market impact signals.
Form 144 is a notice of intent to sell restricted or control securities under Rule 144. Here, the notice lists 21,721 shares of JNJ common stock with an aggregate market value of $4,185,794.26, to be sold approximately on 10/17/2025 via Fidelity Brokerage Services LLC on the NYSE.
The filing notes acquisition on 10/17/2025 from an option granted on 02/15/2024, paid in cash on the same date. It also records 2,408,338,872 shares outstanding and a prior sale in the last three months of 19,137 shares for $3,129,830.51 on 07/17/2025. Actual sales, volume, and timing depend on market conditions and seller decisions.